|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 06/04/16 | Allergan : Obama's inversion curbs kill Pfizer's $160 billion Allergan deal | RE |
| 31/03/16 | Argus Media close to stake sale, Temasek among bidders - sources | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Eric Boyer
IRC | Investor Relations Contact | - | 03/02/2014 |
Carlos Pascual
PRN | Corporate Officer/Principal | - | 12/01/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel H. Yergin
BRD | Director/Board Member | 79 | 26/11/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.06% | +4.04% | -23.05% | +11.69% | 126B | ||
| +3.11% | +1.30% | -41.28% | -16.90% | 45.36B | ||
| +0.44% | +0.40% | -0.51% | +8.67% | 41.1B | ||
| +5.64% | +6.45% | -23.13% | -0.03% | 22.57B | ||
| +0.91% | +2.11% | -37.14% | -35.27% | 18.35B | ||
| -1.03% | -3.48% | +1.58% | +59.34% | 16.35B | ||
| +5.12% | +5.16% | -5.33% | +8.14% | 16.01B | ||
| +4.45% | +7.23% | -20.32% | -30.58% | 10.6B | ||
| -12.42% | -11.58% | +21.79% | +38.37% | 3.57B | ||
| Average | +0.93% | +1.55% | -14.15% | +4.83% | 33.3B | |
| Weighted average by Cap. | +2.11% | +2.85% | -20.66% | +4.42% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















